This paper summarises the factors that led to the formation of the Advisory Council on the Welfare Issues of Dog Breeding and sets out some of the challenges facing the Council. Common to all types of dog is the irresponsible way in which they can be produced, purchased and owned, and the considerable welfare problems that may arise as a direct consequence of these actions. In pedigree and purebred dogs, specific welfare problems may also be the result of the manner in which some of them are bred, as well as a variety of breed-related and inherited disorders and a number of other complex issues. These include the breeding strategies adopted, including cross-breeding for so-called 'designer dog' hybrids, and the influence of showing and judging on the production of over-exaggerated conformational features. The Advisory Council's science-based collaborative approach is key to tackling these issues.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.tvjl.2011.06.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Use of a Continuum-Based Framework to Advance General Health Integration in Community Behavioral Health Clinics.
Psychiatr Serv
January 2025
Montefiore Care Management Organization, New York City (Smali, Chung); Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York City (Finnerty); Department of Psychiatry and Irving Institute for Clinical and Translational Research, Columbia University, and New York State Psychiatric Institute, New York City (Pincus); Behavioral Health Administration, Maryland Department of Health, Baltimore (Talley); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Goldman); private practice, New York City (Woodlock); Department of Psychiatry, Albert Einstein College of Medicine, New York City (Chung).
Objective: This study assessed the utility and effectiveness of the new general health integration (GHI) framework among community behavioral health organizations designated as certified community behavioral health clinics (CCBHCs) or in the process of applying to become a CCBHC.
Methods: Nineteen licensed community behavioral health clinics, 18 of which had CCBHC status, participated in a 12-month learning collaborative. They used the GHI framework to assess their integration stage for 15 subdomains within eight domains of evidence-based practice.
Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey.
Orphanet J Rare Dis
January 2025
Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Heinrich- Heine University, Düsseldorf, Germany.
Background: Patients with Gaucher disease (GD) require continual monitoring; however, lack of specific disease biomarkers was a significant challenge in the past. Glucosylsphingosine (lyso-Gb1) has been shown to be a reliable, key, specific, and sensitive biomarker for diagnosis, prognosis, and treatment response in clinical studies of patients with GD. We evaluated the change in lyso-Gb1 concentration over time following enzyme replacement therapy in patients with confirmed GD using real-world data from the Gaucher Outcome Survey disease registry.
View Article and Find Full Text PDFAdvances in systematic conservation planning to meet global biodiversity goals.
Trends Ecol Evol
January 2025
Department of Marine Sciences, University of the Aegean, Mytilene, 81100, Greece.
Systematic conservation planning (SCP) involves the cost-effective placement and application of management actions to achieve biodiversity conservation objectives. Given the political momentum for greater global nature protection, restoration, and improved management of natural resources articulated in the targets of the Global Biodiversity Framework, assessing the state-of-the-art of SCP is timely. Recent advances in SCP include faster and more exact algorithms and software, inclusion of ecosystem services and multiple facets of biodiversity (e.
View Article and Find Full Text PDFBayesian Optimization Of NeuroStimulation (BOONStim).
Brain Stimul
January 2025
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address:
Baricitinib Provides Significant Improvements in Quality of Life and Functioning in Adults with Moderate-to-Severe Atopic Dermatitis with Baseline Body Surface Area ≤ 40% and Severe Itch.
Dermatol Ther (Heidelb)
January 2025
Department of Dermatology, University of Tsukuba, Tsukuba, Japan.
Introduction: Patients with moderate-to-severe atopic dermatitis (AD), a body surface area (BSA) of ≤ 40%, and an itch numerical rating scale (NRS) score of ≥ 7 ("BARI itch dominant") have been characterized as an important group to consider for the oral janus kinase (JAK) 1/2 inhibitor baricitinib (BARI). Herein we aim to evaluate quality of life (QoL) and functioning outcomes in adult patients with BSA ≤ 40% and itch NRS ≥ 7 at baseline (BL) who received BARI 4 mg in the topical corticosteroid (TCS) combination trial BREEZE-AD7.
Materials: BREEZE-AD7 was a randomized, double-blind, placebo-controlled, parallel-group outpatient study involving adult patients with moderate-to-severe AD who received once-daily placebo or 2-mg or 4-mg BARI in combination with TCS for 16 weeks.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!